{
    "2019-03-14": [
        [
            {
                "time": "2019-03-14",
                "original_text": "After Hours Most Active for Mar 14, 2019: GCP, LLY, HPQ, F, PFE, ACB",
                "features": {
                    "keywords": [
                        "after hours",
                        "most active",
                        "GCP",
                        "LLY",
                        "HPQ",
                        "F",
                        "PFE",
                        "ACB"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "various"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2019-03-14",
                "original_text": "Blue Chip Drug Stocks Face 'Reckoning' on Future Downgrades",
                "features": {
                    "keywords": [
                        "blue chip",
                        "drug stocks",
                        "reckoning",
                        "downgrades"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            }
        ]
    ]
}